Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause Ill-defined disorder? 3,600 Reports in FDA Database

Q: Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN cause Ill-defined disorder?

3,600 reports of Ill-defined disorder have been filed with the FDA for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN, representing 33.6% of all LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN adverse event reports.

Q: How dangerous is Ill-defined disorder from LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN?

Of 3,600 reports, 129 (3.6%) resulted in death and 111 required hospitalization.

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 3,600 reports of Ill-defined disorder have been filed in association with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (PLUVICTO). This represents 33.6% of all adverse event reports for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.

3,600

Reports of Ill-defined disorder with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN

33.6%

of all LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN reports

129

Deaths

111

Hospitalizations

How Dangerous Is Ill-defined disorder From LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN?

Of the 3,600 reports, 129 (3.6%) resulted in death, 111 (3.1%) required hospitalization, and 1 (0.0%) were considered life-threatening.

Is Ill-defined disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN. However, 3,600 reports have been filed with the FAERS database.

What Other Side Effects Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause?

General physical health deterioration (4,332) Death (1,179) Disease progression (286) Malignant neoplasm progression (251) Laboratory test abnormal (233) Prostatic specific antigen increased (212) Fatigue (177) Anaemia (154) Covid-19 (139) Platelet count decreased (130)

What Other Drugs Cause Ill-defined disorder?

ACETAMINOPHEN\OXYCODONE (9,780) ACETAMINOPHEN\HYDROCODONE (6,159) TOCILIZUMAB (4,411) RITUXIMAB (4,220) ETANERCEPT (4,202) METHOTREXATE (4,063) ABATACEPT (3,630) LEFLUNOMIDE (3,570) CERTOLIZUMAB PEGOL (3,273) GOLIMUMAB (3,122)

Which LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Alternatives Have Lower Ill-defined disorder Risk?

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTETIUM OXODOTREOTIDE LU-177 LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTROPIN ALFA LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYMECYCLINE LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYRICA LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYSERGIDE

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Full Profile All Ill-defined disorder Reports All Drugs Causing Ill-defined disorder LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Demographics